Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of therapeutics for chronic liver diseases and viral infections. The firm is focused on the discovery and development of targeted antiviral therapies for chronic hepatitis B (CHB) and coronaviruses, as well as leveraging its expertise in liver diseases to create targeted therapeutics for nonalcoholic steatohepatitis (NASH). The company was founded by Lucinda Quan and Lawrence M. Blatt on February 5, 2018 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
70
Frequently Asked Questions
What is Market Cap of Aligos Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Aligos Therapeutics Inc market cap is $62.74M.
What is the 52-week high for Aligos Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Aligos Therapeutics Inc 52 week high is $46.80 as of September 15, 2025.
What is the 52-week low for Aligos Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Aligos Therapeutics Inc 52 week low is $3.76 as of September 15, 2025.
What is Aligos Therapeutics Inc stock price today?
Aligos Therapeutics Inc stock price today is $9.46.
What was Aligos Therapeutics Inc stock price yesterday?
Aligos Therapeutics Inc stock price yesterday was $10.20.
What is the PE ratio of Aligos Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Aligos Therapeutics Inc’s P/E ratio is -0.52.
What is the Price-to-Book ratio of Aligos Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Aligos Therapeutics Inc P/B ratio is 0.6159.
What is the 50-day moving average of Aligos Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Aligos Therapeutics Inc 50-day moving average is $9.08.
How many employess does Aligos Therapeutics Inc has?